ABOUT US
Prolepha Research B.V. is an independent, privately held Dutch pharmaceutical company, located near Breda in The Netherlands.
We bring to the market a diverse and rapidly growing portfolio of prescription medication, with a strong focus on the patient’s interests. We investigate and apply innovative approaches to help patients in the Netherlands have access to high-quality and affordable prescription medication.
BUSINESS DEVELOPMENT
Prolepha Research B.V. is one of the fastest growing generic pharmaceutical companies in the Netherlands. In order to continue this growth in the future, we are always looking for new business opportunities.
PRODUCTS
Prolepha Research B.V. offers a broad portfolio of generic prescription medication for a diverse range of therapeutic indication areas. Our portfolio is constantly changing. We regularly add affordable new medicines to our range. This contributes to keeping medicine expenditures affordable and to the availability of medicines on the Dutch market.
NEWS
We would like to inform you that Prolepha Research B.V. has added Amisulpride 50 mg, 100 mg, 200 mg and 400 mg tablets to its portfolio. Amisulpride is a unique product for the Dutch market. Previously, Amisulpride was only available as an unregistered pharmacy preparation or via import from abroad. For years Amisulpride has been a proven successful therapy in surrounding countries. Amisulpride will be available on the Dutch market under the brandname Aktiprol. You can find the patient information leaflet on our product page. Do you have any questions? Please contact us via the details you can find on our contact page. * ZI-number: 122727, 122729, 122730, 122731
- 1 July 2020
We would like to inform you that Prolepha Research B.V. has added Codeine Expharma 30mg tablets to its portfolio. You can find the patient leaflet on our product page. Do you have any questions? Please contact us via the contact details on the contact page. * ZI number: 16877993
- 1 May 2020
We would like to inform you that Prolepha Research B.V. has added Lorazepam Prolepha 0.5 mg tablets to its portfolio. Lorazepam Prolepha 0.5 mg is a unique product for the Dutch market. Lorazepam 0.5 mg is a commonly used dose which in the past could only be achieved by breaking a 1 mg tablet. You can find the patient leaflet on our product page. Do you have any questions? Please contact us via the contact details at the contact page. * ZI number: 16869559
- 22 January 2020
We would like to inform you that Prolepha Research B.V. has added Frovatriptan Prolepha 2.5 mg tablets to its portfolio. You can find the patient leaflet on our product page. Do you have any questions? Please contact us via the contact details on the contact page. * ZI number: 16759974
- 1 October 2019
PRODUCTS
BEKIJK ONZE PRODUCTEN
Prolepha Research B.V. biedt een breed portfolio generieke receptgeneesmiddelen aan. Een
receptgeneesmiddel wordt aan de patiënt voorgeschreven door een arts of specialist.
Zoek in onze database naar de beschikbare producten. Gebruik deze feature door op naam te zoeken of suggesties te ontvangen bij invoer van meer dan 3 letters.
